Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease - Wikidata - wikimedia - TriplyDB

Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease

Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease

http://www.wikidata.org/entity/Q34554416

about

Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension Nitric oxide in the normal kidney and in patients with diabetic nephropathy.Do statins prevent acute kidney injury?The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study.Radioprotective effect of atorvastatin against ionizing radiation-induced nephrotoxicity in mice.

P2860

Q36072467-4AA84FE0-644C-44EF-AD60-1FFE1B3F747F Q38248725-8A059543-3826-4AB4-ABE8-4908B94E5063 Q38586166-547021E3-6790-45CC-8BDF-D0EE43BCC4AD Q40088029-C16E07E3-BE2B-4CA7-A973-99C0F7152CC8 Q48363720-202CB8D3-8040-4988-8FD4-6E9E9AE0C0FD

P2860

Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease

http://www.wikidata.org/entity/Q34554416

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@ast

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@en

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@nl

type

label

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@ast

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@en

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@nl

prefLabel

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@ast

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@en

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@nl

P1433

Q34554416-FB1358B0-B9B1-4F33-AA2C-F3866B2828C5

P1476

Q34554416-FFE33C77-3BAF-4AD4-A712-C8DB9667B448

P2093

Q34554416-21B099ED-5A42-492C-90D0-3CCE4C30AF52

Q34554416-326FDC23-CAB4-48B5-A8A4-828F61D95C15

Q34554416-9C9CBA55-F4C7-42ED-935A-F0A334CAB6E4

Q34554416-AB26C9BF-37E2-47A7-89D0-D44BE1E92A14

P2860

Q34554416-0131C170-7473-4ACC-847C-8B9CD7A7102F

Q34554416-0A91A031-CAA6-464E-BDDA-B304CE669D3D

Q34554416-1723ECE6-DA80-4949-BEB2-37DB770EFB61

Q34554416-17603B96-F41C-4AA9-9B76-828EC7D3674C

Q34554416-206324D6-1D54-446B-9816-569A0F41F06C

Q34554416-283DF016-1057-4D4C-AFD5-413425CDF5DC

Q34554416-2944BE3C-4C39-47BE-97AD-E756187644A8

Q34554416-4B16F649-D3E2-4AF6-9B1F-BBD9BBEA4194

Q34554416-4D5D0480-66C5-4614-8A59-D7D6C66A83C5

Q34554416-4FDD1F2D-1B8B-47B4-BA40-055B9F0097AC

P304

Q34554416-DCB86857-478D-4432-8C1A-1B3221DE5E68

P31

Q34554416-73CCAAA9-9CA7-4988-B0B4-8A1B2B6F0E51

P356

Q34554416-D101AA6E-26D1-431F-8E67-68B4CA73C06C

P407

Q34554416-E27FDC62-5379-46AA-BB79-50B78D8D52F7

P433

Q34554416-49520D62-4FD4-4513-8945-15A3C4E86F63

P478

Q34554416-9C224748-BACB-4C6C-8F46-BD26DB8901D9

P50

Q34554416-310E83B6-8C41-40D3-8C73-A89F5665E3E6

Q34554416-83679F51-A987-403D-A055-585E72F22F9C

P577

Q34554416-2087B2BF-18E7-4A4B-A9B6-85564F864952

P5875

Q34554416-894B0659-2B3C-48F1-9C78-A6A7F5EC7412

P698

Q34554416-7867D0EE-334F-4252-A40E-A26FB2407373

P932

Q34554416-EE0A8E37-7621-445E-8A71-BB0E12BFEEDE

P356

P1433

British Journal of Clinical Pharmacology

P1476

Effects of atorvastatin on sys ...... II-III chronic kidney disease

@en

P2093

Annebirthe Bo Hansen

http://www.w3.org/2001/XMLSchema#string

Erling Bjerregaard Pedersen

http://www.w3.org/2001/XMLSchema#string

Janni Majgaard Jensen

http://www.w3.org/2001/XMLSchema#string

Thomas Larsen

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors

Organization of the ENaC-regulatory machinery

The mechanisms of aquaporin control in the renal collecting duct.

Regulation of the abundance of renal sodium transporters and channels by vasopressin.

Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells.

Role of nitric oxide in the regulation of nephron transport.

Simvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase.

Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects

Nitric oxide in the kidney: functions and regulation of synthesis.

Activation of the epithelial Na+ channel in the collecting duct by vasopressin contributes to water reabsorption.

P304

789-799

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.12390

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P50

Jesper Noergaard Bech

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261330711

http://www.w3.org/2001/XMLSchema#string

P698

24697877

http://www.w3.org/2001/XMLSchema#string

P932

4239973

http://www.w3.org/2001/XMLSchema#string